CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...